TD Cowen Downgrades Boston Scientific to Hold From Buy
TD Cowen cut its rating on Boston Scientific to Hold from Buy. The headline lists a $46 price target.
TD Cowen cut its rating on Boston Scientific to Hold from Buy. The headline lists a $46 price target.